Changeflow GovPing Pharma & Drug Safety EPO Patent Publication EP2026029704A1: Dumbbell...
Routine Notice Added Final

EPO Patent Publication EP2026029704A1: Dumbbell-shaped DNA vectors

Favicon for changeflow.com ChangeBridge: EPO Bulletin - Biotech (C12N)
Published March 18th, 2026
Detected March 24th, 2026
Email

Summary

The European Patent Office has published patent application EP2026029704A1 concerning dumbbell-shaped DNA vectors. The publication date is March 18, 2026, and it falls under the C12N IPC classification for biotechnology. No inventors have been designated yet.

What changed

The European Patent Office (EPO) has published patent application EP2026029704A1, titled "DUMBBELL-SHAPED DNA VECTORS." This publication, dated March 18, 2026, relates to biotechnology and intellectual property within the European Union. The application is classified under IPC codes C12N 15/67, C12N 15/85, and others related to genetic engineering and pharmaceutical applications.

This is a patent publication, not a regulatory rule or guidance with direct compliance obligations for companies. However, it signifies potential future intellectual property rights and innovation in the biotechnology and pharmaceutical sectors. Companies operating in these areas should be aware of such publications as they may impact their research, development, and patent strategies. No specific actions or deadlines are imposed by this publication.

Source document (simplified)

← EPO Patent Bulletin

DUMBBELL-SHAPED DNA VECTORS

Publication EP2026029704A1 Kind: A1 Mar 18, 2026

Inventors

The designation of the inventor has not yet been filed

IPC Classifications

C12N 15/67 20060101AFI20260208BHEP C12N 15/85 20060101ALI20260208BHEP A61K 48/00 20060101ALI20260208BHEP A61K 39/215 20060101ALI20260208BHEP A61P 3/00 20060101ALI20260208BHEP A61P 31/14 20060101ALI20260208BHEP C12N 15/88 20060101ALI20260208BHEP C12N 15/50 20060101ALI20260208BHEP C12N 15/53 20060101ALI20260208BHEP C12N 15/54 20060101ALI20260208BHEP C12N 5/10 20060101ALI20260208BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, ME, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →

Source

Analysis generated by AI. Source diff and links are from the original.

Classification

Agency
EPO
Published
March 18th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
EP2026029704A1

Who this affects

Applies to
Drug manufacturers Pharmaceutical companies
Industry sector
3254 Pharmaceutical Manufacturing 3254.1 Biotechnology
Activity scope
Biotechnology Research Drug Development
Geographic scope
European Union EU

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Legal
Topics
Biotechnology Intellectual Property

Get Pharma & Drug Safety alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when ChangeBridge: EPO Bulletin - Biotech (C12N) publishes new changes.

Free. Unsubscribe anytime.